Clin2
NCT07029126Possibly a fitRecruiting

Fremanezumab for migraine with depression: caregiver impact study

Migraine

Treatments studied

Part of Brain & nervous system clinical trials.

This trial tests if fremanezumab, a migraine prevention drug, can also reduce the stress and improve the relationship between migraine patients with mild depression and their caregivers. If you or someone you care for has migraines and low mood, this study may help understand how the caregiver is affected.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
300 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You have migraines (with or without aura) or chronic migraines, and they started before age 50.
  • You have mild depressive symptoms (score ≥5 on a standard depression questionnaire).
  • You have a partner or family member (18 or older) who lives with you and helps with daily tasks—they cannot have migraines or major depression.
  • You are about to start fremanezumab for migraine prevention and have not used similar drugs before.
  • You and your caregiver are willing to fill out daily diaries and questionnaires most of the time.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07579481Recruiting
Vortioxetine for Depression with Migraine

This study tests whether vortioxetine, a depression medication, can help people who have both depression and episodic migraine (recurring headaches). You'd take vortioxetine for depression while researchers track how it affects both your mood and migraine symptoms.

Rome, Lazio
NCT03539393AVAILABLE
Fremanezumab access for pediatric patients

This trial provides continued access to fremanezumab for children and teens who have already completed a related study. It aims to offer ongoing treatment safely under a doctor's supervision.

NCT07451769Recruiting
Testing a new drug target for migraine relief

This trial tests a substance that activates adrenomedullin receptors, which may be a new way to treat migraines. It may help people who have migraines without aura and aren't on preventive migraine medications.

Glostrup Municipality
NCT07071506Recruiting
New tools to track migraine prevention

This study tests new ways to monitor how well preventive migraine treatments are working. It is for people with chronic migraine who may be starting or already using preventive medications.

Aarhus C, Denmark
NCT04715685Recruiting
Mind-body balance program for children with migraine

This trial studies a mind-body balance approach to help reduce symptoms and disability from pediatric migraine. You may join if your child has migraine headaches and can follow study routines, including keeping a headache diary.

Aurora, Colorado
NCT05889624Recruiting
Study of treatments for childhood migraine headaches

This study looks at ways to help children and teens with migraine headaches by testing a care approach that includes access to evidence-based treatment. It may help if your child has frequent migraine headaches and is starting (or not already on) certain migraine-preventive medicines.

Birmingham, Alabama

Hear when a new Migraine trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.